Saf Health Work.
2022 Mar;13(1):126-128. 10.1016/j.shaw.2021.12.700.
Letter to the Editor Regarding “Risk Assessment for Toluene Diisocyanate and Respiratory Disease Human Studies”
- Affiliations
-
- 1American Chemistry Council, Washington, DC, USA
- KMID: 2528001
- DOI: http://doi.org/10.1016/j.shaw.2021.12.700
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Letter to the Editor Concerning “Risk Assessment for Toluene Diisocyanate and Respiratory Disease Human Studies”
- Author's Response to Letters to the Editor regarding “Risk Assessment for Toluene Diisocyanate and Respiratory Disease Human Studies”
- A case of occupational asthma with systemic illness due to toluene diisocyanate and diphenylmethane diisocyanate
- Risk Assessment for Toluene Diisocyanate and Respiratory Disease Human Studies
- A case of bronchial asthma induced by toluene diisocyanate(TDI) in the external environment
